Trial intelligence / Profile preview

Modified Simiao Yongan Decoction for Diabetic Foot Ulcers

NCT07808502Not yet recruiting

Sponsor
Chengdu University of Traditional Chinese Medicine
Start
Dec 2026
Primary completion
Jun 2028
Countries
1
01

Overview

Open-label trial of modified Simiao Yongan decoction in diabetic foot ulcer (DFU) (2 arms), sponsored by Chengdu University of Traditional Chinese Medicine. Primary endpoints: Incidence of Major Adverse Limb Events up to 24 months and Incidence of Major Adverse Cardiovascular Events and Major Bleeding up to 24 months. Planned start Dec 2026; status: not yet recruiting.

02

Drugs

modified Simiao Yongan decoction
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT07808502.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07808502.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call